Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Sell
31
TBBB Quote, Financials, Valuation and Earnings
Last price:
$28.85
Seasonality move
:
14.55%
Day range:
$28.33 - $29.25
52-week range:
$21.39 - $35.22
Dividend yield:
0%
P/E ratio:
129.16x
P/S ratio:
1.18x
P/B ratio:
16.23x
Volume:
749.7K
Avg. volume:
596.4K
1-year change:
6.73%
Market cap:
$3.3B
Revenue:
$3.2B
EPS (TTM):
$0.22
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $846.5M | $1.1B | $1.6B | $2.5B | $3.2B | |
| Revenue Growth (YoY) | -- | 34.55% | 42.19% | 53.63% | 26.75% | |
| Cost of Revenues | $731.9M | $969.5M | $1.4B | $2.1B | $2.6B | |
| Gross Profit | $114.6M | $169.5M | $244.8M | $397.4M | $514.8M | |
| Gross Profit Margin | 13.54% | 14.88% | 15.12% | 15.97% | 16.32% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $87.9M | $126.1M | $181.2M | $290.2M | $364M | |
| Other Inc / (Exp) | -$6M | -$6M | $13.2M | $29.5M | $27.4M | |
| Operating Expenses | $106.1M | $150M | $218.9M | $352.5M | $441.8M | |
| Operating Income | $8.5M | $19.4M | $25.9M | $44.8M | $72.9M | |
| Net Interest Expenses | $38.4M | $49.2M | $57.1M | $80M | $60.9M | |
| EBT. Incl. Unusual Items | -$35.9M | -$35.8M | -$18.1M | -$5.7M | $39.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $155.2K | $4.5M | $10M | $11.6M | $21M | |
| Net Income to Company | -$35.9M | -$35.8M | -$18.1M | -$5.7M | $39.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$36.1M | -$40.3M | -$28.1M | -$17.3M | $18.4M | |
| Basic EPS (Cont. Ops) | -$0.32 | -$0.36 | -$0.25 | -$0.15 | $0.17 | |
| Diluted EPS (Cont. Ops) | -$0.32 | -$0.36 | -$0.25 | -$0.15 | $0.13 | |
| Weighted Average Basic Share | $112.2M | $112.2M | $112.2M | $112.2M | $109.2M | |
| Weighted Average Diluted Share | $112.2M | $112.2M | $112.2M | $112.2M | $139.6M | |
| EBITDA | $22.7M | $39.9M | $79M | $137.2M | $191.5M | |
| EBIT | $2.8M | $13.8M | $40M | $75.7M | $108.1M | |
| Revenue (Reported) | $846.5M | $1.1B | $1.6B | $2.5B | $3.2B | |
| Operating Income (Reported) | $8.5M | $19.4M | $25.9M | $44.8M | $72.9M | |
| Operating Income (Adjusted) | $2.8M | $13.8M | $40M | $75.7M | $108.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $518.5M | $746.6M | $837.9M | |
| Revenue Growth (YoY) | -- | -- | -- | 44.01% | 12.23% | |
| Cost of Revenues | -- | -- | $437.9M | $625.3M | $703.7M | |
| Gross Profit | -- | -- | $80.5M | $121.4M | $134.2M | |
| Gross Profit Margin | -- | -- | 15.53% | 16.26% | 16.01% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $73.7M | $102.5M | $120.7M | |
| Other Inc / (Exp) | -- | -- | $15.7M | -$7.6M | $431.1K | |
| Operating Expenses | -- | -- | $73.4M | $102.4M | $119.6M | |
| Operating Income | -- | -- | $7.1M | $19M | $14.5M | |
| Net Interest Expenses | -- | -- | $19.3M | $20M | $13.7M | |
| EBT. Incl. Unusual Items | -- | -- | $3.5M | -$8.6M | $1.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $322.1K | $5M | $5.5M | |
| Net Income to Company | -- | -- | $3.5M | -$8.6M | $1.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $3.1M | -$13.6M | -$4.3M | |
| Basic EPS (Cont. Ops) | -- | -- | $0.03 | -$0.14 | -$0.04 | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.03 | -$0.14 | -$0.04 | |
| Weighted Average Basic Share | -- | -- | $112.2M | $98.9M | $113.8M | |
| Weighted Average Diluted Share | -- | -- | $112.2M | $98.9M | $113.8M | |
| EBITDA | -- | -- | $37.1M | $30.5M | $36.8M | |
| EBIT | -- | -- | $23M | $12.7M | $16.8M | |
| Revenue (Reported) | -- | -- | $518.5M | $746.6M | $837.9M | |
| Operating Income (Reported) | -- | -- | $7.1M | $19M | $14.5M | |
| Operating Income (Adjusted) | -- | -- | $23M | $12.7M | $16.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $2.7B | $3.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $2.3B | $2.7B | |
| Gross Profit | -- | -- | -- | $438.7M | $524.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $318.7M | $385.8M | |
| Other Inc / (Exp) | -- | -- | $26.4M | $5.1M | $34.8M | |
| Operating Expenses | -- | -- | -- | $381.8M | $455.4M | |
| Operating Income | -- | -- | -- | $56.9M | $68.8M | |
| Net Interest Expenses | -- | -- | $36.3M | $80.5M | $54.7M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$18.5M | $48.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $16.5M | $21.5M | |
| Net Income to Company | -- | -- | -- | -$17.7M | $49.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$35M | $27.4M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$0.33 | $0.25 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.33 | $0.22 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | $129.6M | $196M | |
| EBIT | -- | -- | -- | $64.5M | $111.9M | |
| Revenue (Reported) | -- | -- | -- | $2.7B | $3.2B | |
| Operating Income (Reported) | -- | -- | -- | $56.9M | $68.8M | |
| Operating Income (Adjusted) | -- | -- | -- | $64.5M | $111.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $518.5M | $746.6M | $837.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $437.9M | $625.3M | $703.7M | |
| Gross Profit | -- | -- | $80.5M | $121.4M | $134.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $73.7M | $102.5M | $120.7M | |
| Other Inc / (Exp) | -- | -- | $15.7M | -$7.6M | $431.1K | |
| Operating Expenses | -- | -- | $73.4M | $102.4M | $119.6M | |
| Operating Income | -- | -- | $7.1M | $19M | $14.5M | |
| Net Interest Expenses | -- | -- | $19.3M | $20M | $13.7M | |
| EBT. Incl. Unusual Items | -- | -- | $3.5M | -$8.6M | $1.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $322.1K | $5M | $5.5M | |
| Net Income to Company | -- | -- | $3.5M | -$8.6M | $1.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $3.1M | -$13.6M | -$4.3M | |
| Basic EPS (Cont. Ops) | -- | -- | $0.03 | -$0.14 | -$0.04 | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.03 | -$0.14 | -$0.04 | |
| Weighted Average Basic Share | -- | -- | $112.2M | $98.9M | $113.8M | |
| Weighted Average Diluted Share | -- | -- | $112.2M | $98.9M | $113.8M | |
| EBITDA | -- | -- | $37.1M | $30.5M | $36.8M | |
| EBIT | -- | -- | $23M | $12.7M | $16.8M | |
| Revenue (Reported) | -- | -- | $518.5M | $746.6M | $837.9M | |
| Operating Income (Reported) | -- | -- | $7.1M | $19M | $14.5M | |
| Operating Income (Adjusted) | -- | -- | $23M | $12.7M | $16.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $48.9M | $50.5M | $70.4M | $68.3M | |
| Short Term Investments | -- | -- | -- | -- | $148M | |
| Accounts Receivable, Net | -- | $174.6K | $1M | $649K | $4.6M | |
| Inventory | -- | $68.6M | $99.1M | $138.8M | $147.1M | |
| Prepaid Expenses | -- | $1.5M | $2.7M | $4.3M | $3.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $139.9M | $184.6M | $258.7M | $414M | |
| Property Plant And Equipment | -- | $241.8M | $403.2M | $596.4M | $652.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $393.3M | $605M | $881.2M | $1.1B | |
| Accounts Payable | -- | $203.5M | $290.5M | $438.7M | $444.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $13.2M | $21M | $33.1M | $39M | |
| Current Portion Of Capital Lease Obligations | -- | $18.9M | $21.4M | $31.7M | $36.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $243.5M | $349M | $527.2M | $541.4M | |
| Long-Term Debt | -- | $216.5M | $247.1M | $289.6M | $5.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $610.8M | $846.8M | $1.2B | $907.1M | |
| Common Stock | -- | $23M | $24.2M | $27.8M | $400.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -$217.5M | -$241.8M | -$272.9M | $195.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -$217.5M | -$241.8M | -$272.9M | $195.3M | |
| Total Liabilities and Equity | -- | $393.3M | $605M | $881.2M | $1.1B | |
| Cash and Short Terms | -- | $48.9M | $50.5M | $70.4M | $216.3M | |
| Total Debt | -- | $229.7M | $272.3M | $333.4M | $50M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $258.2M | $76.9M | |
| Short Term Investments | -- | -- | -- | -- | $150.3M | |
| Accounts Receivable, Net | -- | -- | -- | $2.7M | $7.1M | |
| Inventory | -- | -- | -- | $131M | $144.5M | |
| Prepaid Expenses | -- | -- | -- | $5.2M | $7.1M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | $444.5M | $427.4M | |
| Property Plant And Equipment | -- | -- | -- | $651.7M | $706.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | $1.1B | $1.2B | |
| Accounts Payable | -- | -- | -- | $458.4M | $474.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $57.2M | $43M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $34.3M | $41.4M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | $560.6M | $576.9M | |
| Long-Term Debt | -- | -- | -- | $6.1M | $6.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $939.4M | $971.6M | |
| Common Stock | -- | -- | -- | $498.3M | $407.7M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $185M | $204.1M | |
| Total Liabilities and Equity | -- | -- | -- | $1.1B | $1.2B | |
| Cash and Short Terms | -- | -- | -- | $258.2M | $227.2M | |
| Total Debt | -- | -- | -- | $63.4M | $49.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$35.9M | -$35.8M | -$18.1M | -$5.7M | $39.4M | |
| Depreciation & Amoritzation | $19.8M | $26.1M | $39M | $61.5M | $83.4M | |
| Stock-Based Compensation | $923.7K | $7M | $15.1M | $21.7M | $28.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$11M | -$21.3M | -$26.3M | -$24M | -$37.4M | |
| Cash From Operations | $50.8M | $67.4M | $105.2M | $177.3M | $205.8M | |
| Capital Expenditures | $14M | $26.3M | $56M | $101.6M | $133.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$13.9M | -$25.8M | -$55.2M | -$100.4M | -$269.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $7.7M | $23.8M | $80.1M | $129.6M | $192.1M | |
| Long-Term Debt Repaid | -$27.5M | -$39.7M | -$33.7M | -$29.8M | -$145.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$5.2M | -$70M | -$117.1M | -$179.8M | |
| Cash From Financing | -$20.9M | -$22.2M | -$51.1M | -$61.8M | $70.7M | |
| Beginning Cash (CF) | $12.9M | $30.1M | $49.7M | $55.6M | $67M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $15.9M | $19.3M | -$1.1M | $15M | $7.1M | |
| Ending Cash (CF) | $28.6M | $49.3M | $49M | $68.9M | $79.4M | |
| Levered Free Cash Flow | $36.8M | $41.1M | $49.2M | $75.7M | $71.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $3.5M | -$8.6M | $1.2M | |
| Depreciation & Amoritzation | -- | -- | $14.1M | $17.8M | $19.9M | |
| Stock-Based Compensation | -- | -- | $5.3M | $7.6M | $10.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -$6.1M | $10.6M | $4.5M | |
| Cash From Operations | -- | -- | $31.5M | $47.2M | $58.4M | |
| Capital Expenditures | -- | -- | $18.1M | $22.6M | $26.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$17.9M | -$21.5M | -$25M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $20.6M | $53.1M | $57.9M | |
| Long-Term Debt Repaid | -- | -- | -$19.1M | -$298.7M | -$15M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$24.1M | -$40.7M | -$55M | |
| Cash From Financing | -- | -- | -$22.8M | $159.8M | -$27.7M | |
| Beginning Cash (CF) | -- | -- | $52.7M | $71.8M | $70.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$1M | -$4.7M | $60.4K | |
| Additions / Reductions | -- | -- | -$9.3M | $185.5M | $5.8M | |
| Ending Cash (CF) | -- | -- | $42.4M | $252.7M | $76.7M | |
| Levered Free Cash Flow | -- | -- | $13.4M | $24.6M | $31.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$17.7M | $49.2M | |
| Depreciation & Amoritzation | -- | -- | -- | $65.2M | $85.5M | |
| Stock-Based Compensation | -- | -- | $5.3M | $24M | $31.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -$7.4M | -$43.5M | |
| Cash From Operations | -- | -- | -- | $193M | $217M | |
| Capital Expenditures | -- | -- | $18.1M | $106.1M | $138M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$104M | -$272.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $162.1M | $196.9M | |
| Long-Term Debt Repaid | -- | -- | -- | -$309.5M | $137.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$133.8M | -$194M | |
| Cash From Financing | -- | -- | -- | $120.8M | -$116.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $209.8M | -$172.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $86.9M | $79M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $3.5M | -$8.6M | $1.2M | |
| Depreciation & Amoritzation | -- | -- | $14.1M | $17.8M | $19.9M | |
| Stock-Based Compensation | -- | -- | $5.3M | $7.6M | $10.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -$6.1M | $10.6M | $4.5M | |
| Cash From Operations | -- | -- | $31.5M | $47.2M | $58.4M | |
| Capital Expenditures | -- | -- | $18.1M | $22.6M | $26.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$17.9M | -$21.5M | -$25M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $20.6M | $53.1M | $57.9M | |
| Long-Term Debt Repaid | -- | -- | -$19.1M | -$298.7M | -$15M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$24.1M | -$40.7M | -$55M | |
| Cash From Financing | -- | -- | -$22.8M | $159.8M | -$27.7M | |
| Beginning Cash (CF) | -- | -- | $52.7M | $71.8M | $70.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$1M | -$4.7M | $60.4K | |
| Additions / Reductions | -- | -- | -$9.3M | $185.5M | $5.8M | |
| Ending Cash (CF) | -- | -- | $42.4M | $252.7M | $76.7M | |
| Levered Free Cash Flow | -- | -- | $13.4M | $24.6M | $31.6M | |
Get TBBB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TBBB
Sector
P/E ratio
129.16x
18.91x
PEG ratio
--
0.25x
P/B ratio
16.23x
1.57x
Price / LTM sales
1.18x
0.62x
Growth Metrics
TBBB
Sector
Revenue growth
12.23%
-0.73%
Earnings growth
378.65%
0.61%
Revenue (5-year growth)
--
4.07%
Earnings forecast
$0.04
$0.32
Profitability
TBBB
Sector
Profitability FY 2024
$514.8M
$516.7M
Return on invested capital
10.97%
5.2%
Return on assets
2.48%
3.45%
Return on equity
14.02%
8%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
21
Estimated Next Earnings Date
Aug
7
Balance Sheet
TBBB
Sector
Total cash
$227.2M
$131.4M
Short term investments
$148M
$41.9M
Total assets
$1.1B
$1.8B
Long term debt
$49.3M
$200.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
